🇺🇸 FDA
Patent

US 12304942

Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

granted A61KA61K40/11A61K40/31

Quick answer

US patent 12304942 (Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor) held by AUTOLUS LIMITED expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/4204, A61K40/4211